Additional androgen deprivation makes the difference: Biochemical recurrence-free survival of D'Amico intermediate and high-risk prostate cancer patients after combined HDR-brachytherapy and external beam radiotherapy

被引：0
|
作者：
Schwarz, R. [1 ]
Schiffmann, J. [2 ]
Lesmana, H. [1 ]
Tennstedt, P. [2 ]
Beyer, B. [2 ]
Boehm, K. [2 ]
Platz, V [1 ]
Tilki, D. [2 ]
Salomon, G. [2 ]
Graefen, M. [2 ]
Kruell, A. [1 ]
Petersen, C. [1 ]
机构：
[1] Klin Strahlentherapie & Radioonkol UKE, Hamburg, Germany
[2] Martiniklinik, Hamburg, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-01-11
引用
收藏
页码：S54 / S55
页数：2
相关论文
共 50 条
  • [1] Additional androgen deprivation makes the difference Biochemical recurrence-free survival in prostate cancer patients after HDR brachytherapy and external beam radiotherapy
    Schiffmann, Jonas
    Lesmana, Hans
    Tennstedt, Pierre
    Beyer, Burkhard
    Boehm, Katharina
    Platz, Volker
    Tilki, Derya
    Salomon, Georg
    Petersen, Cordula
    Kruell, Andreas
    Graefen, Markus
    Schwarz, Rudolf
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (04) : 330 - 337
  • [2] HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation for intermediate and high risk prostate cancer
    Kurek, R
    Martin, T
    Röddiger, SJ
    Sapoutzis, N
    Dannenberg, T
    Rogge, B
    Baltas, W
    Tunn, UW
    Zamboglou, N
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 70 - 70
  • [3] Additional androgen deprivation makes the difference: Biochemical recurrence-free survival in prostate cancer patients after HDR brachytherapy and external beam radiotherapy [Zusätzlicher Androgenentzug macht den Unterschied: Biochemisches rezidivfreies Überleben bei Prostatakarzinompatienten nach HDR-Brachytherapie und perkutaner Bestrahlung]
    Schiffmann J.
    Lesmana H.
    Tennstedt P.
    Beyer B.
    Boehm K.
    Platz V.
    Tilki D.
    Salomon G.
    Petersen C.
    Krüll A.
    Graefen M.
    Schwarz R.
    Strahlentherapie und Onkologie, 2015, 191 (4) : 330 - 337
  • [4] Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer
    Ohashi, Toshio
    Yorozu, Atsunori
    Saito, Shiro
    Momma, Tetsuo
    Nishiyama, Toru
    Yamashita, Shoji
    Shiraishi, Yutaka
    Shigematsu, Naoyuki
    RADIATION ONCOLOGY, 2014, 9
  • [5] Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer
    Toshio Ohashi
    Atsunori Yorozu
    Shiro Saito
    Tetsuo Momma
    Toru Nishiyama
    Shoji Yamashita
    Yutaka Shiraishi
    Naoyuki Shigematsu
    Radiation Oncology, 9
  • [6] Follow-up analysis of combined HDR-brachytherapy and external beam radiotherapy for prostate cancer patients
    Siebert, F. A.
    Juergens, L.
    Dunst, J.
    Jiang, P.
    Nuernberg, N.
    Galalae, R.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S561 - S561
  • [7] Trial Participation is Not Associated with Better Biochemical Recurrence-free Survival in a Large Cohort of External Beam Radiotherapy-Treated Intermediate- and High-Risk Prostate Cancer Patients
    Flammia, R. S.
    Lavigne, D.
    Tian, Z.
    Saad, F.
    Anceschi, U.
    Gallucci, M.
    Leonardo, C.
    Preisser, F.
    Mandel, P.
    Chun, F. K. H.
    Karakiewicz, P., I
    Delouya, G.
    Taussky, D.
    Hoeh, B.
    CLINICAL ONCOLOGY, 2023, 35 (01) : E77 - E84
  • [8] Biochemical Relapse-free Survival after External Beam Radiation and Brachytherapy for Prostate Cancer Patients Having Intermediate and High-risk Features
    Shasha, D.
    Nabhani, T.
    Nadelson, A.
    Patton, B.
    Salant, R.
    Harrison, L. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S337 - S337
  • [9] Combined High Dose Rate (HDR) Brachytherapy with External Beam Radiotherapy (EBRT) Results in a High Rate of Biochemical Disease Free Survival (DFS) in Localised Intermediate and High Risk Prostate Cancer Patients
    Joseph, N.
    Taylor, C.
    Choudhury, A.
    Elliott, T.
    Logue, J.
    Wylie, J.
    CLINICAL ONCOLOGY, 2016, 28 (05) : E13 - E13
  • [10] Quality of life in intermediate or high risk prostate cancer patients treated by external beam radiotherapy and brachytherapy with or without androgen deprivation
    Lacorte-Pi, T. M.
    Guix-Melcior, B.
    Guedea-Edo, F.
    PSYCHO-ONCOLOGY, 2006, 15 (02) : S296 - S297
12345